Original ResearchPublished 16 September 2026Corifollitropin alfa versus daily recombinant FSH for ovarian stimulation in women of advanced maternal age: a cost-minimization analysis in an out-of-pocket settingG. N. Cecchino · B. R. Carvalho · Y. Ramires · R. L. P. Bueno · L. A. Lucio · V. P. SantanaFrontiers in Reproductive Healthdoi 10.3389/frph.2026.1939114